Address: Of. 218, bld. 2, 11a, Seleznevskaya str., Moscow 127473,Russia
Tel: (495) 741-65-19
The Union of Professional Pharmaceutical Organizations (SPFO) was registered in May 2002, to unite the largest Russian and foreign distributors and pharmaceutical manufacturers, which account for more than 50% of the total volume of drugs circulating in the market .
At this point in the SPFO includes 36 organizations : manufacturers, distributors, drugstore chains, public organizations and companies representing the media.
The supreme governing body SPFO a general meeting. Current work SPFO directs the Supervisory Board of 14 members. Chairman of the Supervisory Board is Yakunin, VS (CV Protek). Executive Director of the Union is a seasoned professional pharmaceutical organizations Shirshov GP
SPFO activities organized on the principle of specific programs and projects. Basic principles of decision making in SPFO – collegiality and democracy.
The main objectives of SPFO are:
•promote the development of the pharmaceutical market in Russia;
•opposition to unethical business practices in the pharmaceutical industry;
•assist in balancing the interests of the pharmaceutical market participants, government and consumers;
•development and expansion of the capacity of members SPFO.
•protection of consumer interests in terms of quality and affordability of drugs;
•support structures of the government in addressing the strategic development objectives of pharmaceutical market;
•Members SPFO coordination in joint projects;
•Providing a forum for free communication between members of the pharmaceutical market;
•upholding the rights and legitimate interests of the members SPFO;
•cooperation with the legislative and executive authorities, public, nonprofit and international organizations;
•popularization of progressive experience of SPFO and its members.
Currently SPFO the following programs and projects:
•Harmonization of legislation;
•Assistance in establishing a system of drug reimbursement in the Russia;
•Promotion of international quality standards in the pharmaceutical industry (GMP / GXP);
•Assist in improving the system of public procurement of medicines;
•Forming the system of scientific-practical conferences on topical issues of the pharmaceutical industry;
•The program ‘A Place Pharmacy in a single economic space’;
•Organizing and conducting an annual ‘International Forum / Exhibition / Fair on’ Innovative Technologies for Health ‘;
•The organization’s annual charity ball dispensers;
•Edition of the journal ‘Health management’.
With the announcement of the Pharma 2020 strategy to develop the domestic pharmaceutical industry, multinational…
You founded Euroservice, and have managed this business since its inception in 1996. What are the key drivers that…
In spring of 2010, Protek became the first Russian wholesaler to enter the public stock market, raising $400Mn in…
PAREXEL prides itself on improving the time schedule of a product launch. What is the significance of…
Since our last report on Russia in 2007, there has been much emphasis placed on developing local industry, and…
You worked for ten years at Schering-Plough—one of the largest pharmaceutical companies in the world. In…
You have been at your current position for less than a year, and joined BIOCODEX after having managed the Russian…
Russia and India have recently held a number of discussions regarding increased cooperation within the…
Biofund is an independent spin-off of the broader Russian Venture Capital organization. What is the working…
Petrovax has always been an innovative company, making it quite unique in Russia where the domestic industry is…
After a long history in Philips, this is your first tenure as a regional CEO. Having been at this position for less…